These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32558590)

  • 21. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
    Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
    Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Office management of peripheral arterial disease.
    Aronow WS
    Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug treatment of peripheral arterial disease in the elderly.
    Aronow WS
    Drugs Aging; 2006; 23(1):1-12. PubMed ID: 16492065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease.
    Di Minno G; Spadarella G; Cafaro G; Petitto M; Lupoli R; Di Minno A; de Gaetano G; Tremoli E
    Ann Med; 2014 Nov; 46(7):475-89. PubMed ID: 25045928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Evidence and Future Perspectives on Anti-platelet and Statin Pharmacotherapy for Patients with Symptomatic Peripheral Arterial Disease.
    Kitrou P; Katsanos K; Karnabatidis D; Reppas L; Brountzos E; Spiliopoulos S
    Curr Vasc Pharmacol; 2017; 15(5):430-445. PubMed ID: 28595535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging drugs in peripheral arterial disease.
    Tulsyan N; Ouriel K; Kashyap VS
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):75-90. PubMed ID: 16503827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic Therapy in Lower Extremity Artery Disease.
    Vrsalovic M; Aboyans V
    Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.
    Zeymer U; Parhofer KG; Pittrow D; Binz C; Schwertfeger M; Limbourg T; Röther J
    Clin Res Cardiol; 2009 Apr; 98(4):249-56. PubMed ID: 19221687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of aspirin and clopidogrel resistance in peripheral arterial disease.
    Guirgis M; Thompson P; Jansen S
    J Vasc Surg; 2017 Nov; 66(5):1576-1586. PubMed ID: 28893489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of Guideline-Directed Medical Therapy in Patients Undergoing Endovascular Procedures for Critical Limb Ischemia.
    Llanos-Chea F; Jelani QU; Trejo-Paredes C; Curtis JP; Parzynski CS; Huang J; Faridi KF; Turner J; Smolderen KG; Mena-Hurtado C
    J Am Coll Cardiol; 2021 Mar; 77(10):1374-1375. PubMed ID: 33706882
    [No Abstract]   [Full Text] [Related]  

  • 33. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation.
    Rivera-Caravaca JM; Camelo-Castillo A; Ramírez-Macías I; Gil-Pérez P; López-García C; Esteve-Pastor MA; Orenes-Piñero E; Tello-Montoliu A; Marín F
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatments for peripheral artery disease.
    Bartholomew J; Bishop GJ
    Cleve Clin J Med; 2020 May; 87(5 suppl 1):21-25. PubMed ID: 32349971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease.
    Hunter MR; Cahoon WD; Lowe DK
    Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical therapy for peripheral arterial disease.
    Simmons A; Steffen K; Sanders S
    Curr Opin Cardiol; 2012 Nov; 27(6):592-7. PubMed ID: 23032711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet agents for intermittent claudication.
    Wong PF; Chong LY; Mikhailidis DP; Robless P; Stansby G
    Cochrane Database Syst Rev; 2011 Nov; (11):CD001272. PubMed ID: 22071801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of Vasculoprotective Therapy for Peripheral Artery Disease: A Systematic Review and Meta-analysis.
    Hackam DG; Vyas MV
    Am J Med; 2018 Nov; 131(11):1332-1339.e3. PubMed ID: 30056102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical considerations after endovascular therapy of peripheral artery disease.
    Giannopoulos S; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2021 May; 19(5):369-378. PubMed ID: 33870848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.